Overview of recall records associated with Dr. Reddy's Laboratories, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 50, Class III: 33, Class I: 3.
Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000…
Presence of Foreign Substance: Product complaint of black speckles observed on tablets.
Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.
Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin…
Presence of Foreign Substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle.
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.
Failed Stability Specifications:Out-of-specification results observed for viscosity during stability testing.
Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.
Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesnt match the lot number printed on the bottle
Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for…
Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
Failed dissolution specifications - low dissolution results at S3 stage.
Failed dissolution specifications - low dissolution results at S3 stage.
Failed dissolution specifications - low dissolution results at S3 stage.
This page summarizes recall records in which the official source identifies Dr. Reddy's Laboratories, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.
